Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 36.29 ($0.48) and traded as low as GBX 21 ($0.28). Beximco Pharmaceuticals shares last traded at GBX 22 ($0.29), with a volume of 2,374,320 shares traded.
Beximco Pharmaceuticals Stock Performance
The firm has a market capitalization of £95.91 million, a price-to-earnings ratio of 275.00 and a beta of 0.64. The stock’s fifty day moving average is GBX 32.14 and its two-hundred day moving average is GBX 36.29. The company has a quick ratio of 0.37, a current ratio of 1.80 and a debt-to-equity ratio of 14.73.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Featured Articles
- Five stocks we like better than Beximco Pharmaceuticals
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Consumer Discretionary Stocks Explained
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
